Littérature scientifique sur le sujet « Antigeni tumore associati »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Antigeni tumore associati ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Antigeni tumore associati"
Polito, M., L. Possati, G. Muzzonigro et V. Beatrici. « Identificazione Di Antigeni Tumore Associati Con La Tecnica Dell'Immunofluorescenza Su Cellule Uroteliali Neoplastiche ». Urologia Journal 57, no 5 (octobre 1990) : 546–48. http://dx.doi.org/10.1177/039156039005700516.
Texte intégralKrishnan, Lakshmi, Lise Deschatelets, Felicity C. Stark, Komal Gurnani et G. Dennis Sprott. « Archaeosome Adjuvant Overcomes Tolerance to Tumor-Associated Melanoma Antigens Inducing Protective CD8+T Cell Responses ». Clinical and Developmental Immunology 2010 (2010) : 1–13. http://dx.doi.org/10.1155/2010/578432.
Texte intégralYang, Changlin, Kyle Dyson, Oleg Yegorov et Duane Mitchell. « IMMU-24. A COMPREHENSIVE IN SILICO APPROACH TO DISCOVERING TUMOR REJECTION ANTIGENS IN MALIGNANT BRAIN TUMORS ». Neuro-Oncology 21, Supplement_6 (novembre 2019) : vi124. http://dx.doi.org/10.1093/neuonc/noz175.517.
Texte intégralZhao, Jiaxuan, Guangsheng Du et Xun Sun. « Tumor Antigen-Based Nanovaccines for Cancer Immunotherapy : A Review ». Journal of Biomedical Nanotechnology 17, no 11 (1 novembre 2021) : 2099–113. http://dx.doi.org/10.1166/jbn.2021.3178.
Texte intégralHaupt, Katharina, Michael Roggendorf et Klauss Mann. « The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy ». Experimental Biology and Medicine 227, no 4 (avril 2002) : 227–37. http://dx.doi.org/10.1177/153537020222700403.
Texte intégralFischer, Duncan K., Terence L. Chen et Raj K. Narayan. « Immunological and biochemical strategies for the identification of brain tumor-associated antigens ». Journal of Neurosurgery 68, no 2 (février 1988) : 165–80. http://dx.doi.org/10.3171/jns.1988.68.2.0165.
Texte intégralCraig, Vanessa J., Isabelle Arnold, Christiane Gerke, Minh Q. Huynh, Thomas Wündisch, Andreas Neubauer, Christoph Renner, Stanley Falkow et Anne Müller. « Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins ». Blood 115, no 3 (21 janvier 2010) : 581–91. http://dx.doi.org/10.1182/blood-2009-06-228015.
Texte intégralFu, C., H. Zhao, Y. Wang, H. Cai, Y. Xiao, Y. Zeng et H. Chen. « Tumor-associated antigens : Tn antigen, sTn antigen, and T antigen ». HLA 88, no 6 (28 septembre 2016) : 275–86. http://dx.doi.org/10.1111/tan.12900.
Texte intégralKaran, Dev, Seema Dubey et Brantley Thrasher. « Dual antigen target based immunotherapy for prostate cancer eliminates the growth of established tumors in mice (155.3) ». Journal of Immunology 186, no 1_Supplement (1 avril 2011) : 155.3. http://dx.doi.org/10.4049/jimmunol.186.supp.155.3.
Texte intégralDyson, Kyle, Changlin Yang, Vrunda Trivedi, Tyler Wildes, Adam Grippin et Duane Mitchell. « IMMU-49. PREDICTING PATIENT-SPECIFIC ANTIGENS FOR MEDULLOBLASTOMA IMMUNOTHERAPY ». Neuro-Oncology 22, Supplement_2 (novembre 2020) : ii115. http://dx.doi.org/10.1093/neuonc/noaa215.479.
Texte intégralThèses sur le sujet "Antigeni tumore associati"
DI, CRISTANZIANO VERONICA. « Caratterizzazione e valutazione del ruolo immunologico di un nuovo antigene associato all'adenocarcinoma del colon-retto : colorectal tumor-associated antigen 1 (COA-1) ». Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2008. http://hdl.handle.net/2108/432.
Texte intégralRecently, a new colorectal cancer (CRC)-associated antigen, denominated colorectal tumorassociated antigen-1 (COA-1), recognized by CD4+ T lymphocytes in a HLA class IIrestricted way and encoded by UBXD5 gene, was identified. In this study, we evaluated whether COA-1 can evoke a specific T cell-mediated response in CRC patients and whether this antigen can represent a tool to design new protocols of immunotherapy and a marker for the progression of the disease. Peripheral blood lymphocytes isolated from CRC patients have been in vitro stimulated with the immunogenic epitope of COA-1441-460 (FSTFPPTLYQDDTLTLQAAG) and the antigen- and tumor immunological response was analyzed by IFN-g ELISPOT assay. We could isolate COA-1 specific and tumor reactive T lymphocytes from all (n= 7) HLADRb1* 0402+ or *1301+ CRC patients with progressive disease (Dukes’ C and D), but not in patients (n= 4) with early stage tumor (Dukes’ A and B). Furthermore, these T lymphocytes had a CD3+CD4+CD69+CD45RA+ phenotype, compatible with the activated effector-type T cell subset, and most of them exerted cytotoxic activity against tumor cells expressing COA-1 and the specific MHC restriction elements. In addition, we have verified whether COA-1 specific reactivity could be isolated from PBMCs of CRC patients by the usage of autologous dendritic cells loaded with tumor lysate. Tumor reactive and COA-1 specific CD4+ T cells colud be isolated by in vitro stimulation of PBMCs either with intact tumor cells and with DC pulsed with tumor lysate, suggesting that this antigen can generate a dominant immunological response against CRC. In conclusion, the results of this study indicate that COA-1 can be a relevant antigen for the anti-tumor immune response in CRC patients, correlating with the progression of the disease, and suggest that this molecule is suitable for immunotherapeutic protocols of these patients.
Nastke, Maria-Dorothea. « T-cell epitopes from viral and tumor associated antigens induction and analysis of antigen-specific T cells / ». [S.l. : s.n.], 2005. http://www.bsz-bw.de/cgi-bin/xvms.cgi?SWB12168223.
Texte intégralLotz, Carina. « Tolerance and immunity to human tumor-associated antigens ». [S.l.] : [s.n.], 2003. http://deposit.ddb.de/cgi-bin/dokserv?idn=970660308.
Texte intégralSheu, Fong-Shyong. « Characterizations of a tumor-associated antigen COX-1 ». Thesis, University of British Columbia, 1991. http://hdl.handle.net/2429/30332.
Texte intégralMedicine, Faculty of
Obstetrics and Gynaecology, Department of
Graduate
Ullenhag, Gustav. « Vaccine Therapy of Colorectal Cancer Patients with Tumor Associated Antigens ». Doctoral thesis, Uppsala University, Oncology, 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3399.
Texte intégralIn this thesis, two different vaccines were evaluated as adjuvant therapy for patients with colorectal cancer. The ability of the two candidate vaccines to generate antigen-specific cellular and humoral responses, respectively, was studied. The effectiveness of granulocyte colony stimulating factor (GM-CSF) as a cytokine adjuvant to augment the immune response was also examined.
The first vaccination strategy involved immunization with the recombinant tumor-associated protein, carcinoembryonic antigen (CEA). Recombinant CEA was administered at 4 different dose levels 7 times during one year. Peripheral blood samples were regularly analyzed during 36 months. This vaccination regimen induced a strong immunoglobulin 1 (IgG1) and IgG4 response, a moderate IgG2 response and a weak IgG3 response against CEA. GM-CSF markedly augmented the effect on IgG1 and IgG4 as well as the T cell response. In contrast, dose of rCEA had no or modest effect on induced immune responses. The response gradually increased during the 12 months immunization period. Responses of all three IgG subclasses and of T cells were protracted up to 36 months. The anti-CEA IgG titers related significantly to survival. Functional HLA-DR epitopes of CEA could be defined. These major histocompatibility class II epitopes may serve as putative components of a peptide-based vaccination strategy.
The other vaccine strategy consisted of the tumor-associated antigen epithelial cell adhesion molecule (Ep-Cam) expressed as a transgene in a viral vector, ALVAC. Patients were immunized subcutaneously/intradermally 3 times over 6 weeks and monitored for immune responses for 46 weeks. No anti-Ep-Cam specific humoral response was induced, but Ep-Cam specific type 1 T cells (interpheron-gamma production) were induced, mainly in the GM-CSF group. The cytotoxic cellular response appeared late, or a few months after the last immunization.
Both vaccines were well tolerated. Since GM-CSF was an important component for both regimens, immungenicity of this cytokine was assessed. Multiple immunizations with low dose GM-CSF were associated with a low incidence of GM-CSF antibodies that did not neutralize the biological effect of GM-CSF.
In conclusion, both vaccines are promising candidate vaccines. GM-CSF is necessary to induce a strong humoral and cellular immune response. Large clinical trials are urgently warranted to evaluate the clinical efficacy.
Hishizawa, Masakatsu. « Identification of tumor-associated antigens in hematological malignancies by SEREX ». Kyoto University, 2006. http://hdl.handle.net/2433/143835.
Texte intégralShi, Mengchao. « Design and Synthesis of a Novel Entirely Carbohydrate-Based Conjugate for Cancer Vaccine Development ». University of Toledo / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1470412718.
Texte intégralDullforce, Per. « Cytotoxicity mediated by monoclonal antibodies to tumour associated antigens ». Thesis, University of Nottingham, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293660.
Texte intégralRuiz, Elena. « DNA fusion vaccines against HPV16 E7 antigen-associated cancers ». Thesis, University of Southampton, 2011. https://eprints.soton.ac.uk/374745/.
Texte intégralSchecter, Robyn Lee. « A double determinant serum assay for detecting breast tumor associated antigen / ». Thesis, McGill University, 1987. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=66270.
Texte intégralLivres sur le sujet "Antigeni tumore associati"
C, Ghosh Bimal, et Ghosh Luna, dir. Tumor markers and tumor-associated antigens. New York : McGraw-Hill, 1987.
Trouver le texte intégralGires, Olivier, et Barbara Seliger. Tumor-associated antigens : Identification, characterization, and clinical applications. Weinheim : Wiley-VCH, 2009.
Trouver le texte intégralChuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Berlin, Heidelberg : Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-46848-7.
Texte intégralHamburger Symposium über Tumormarker. (6th 1991 Hamburg, Germany). Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the Nineties : 6th Symposium on Tumor Markers, Hamburg 1991. München : W. Zuckschwerdt Verlag, 1992.
Trouver le texte intégralGires, Olivier, et Barbara Seliger, dir. Tumor‐Associated Antigens. Wiley, 2009. http://dx.doi.org/10.1002/9783527625970.
Texte intégralTumor-Associated Antigens : Identification, Characterization, and Clinical Applications. Wiley-VCH Verlag GmbH, 2009.
Trouver le texte intégralGires, Olivier, et Barbara Seliger. Tumor-Associated Antigens : Identification, Characterization, and Clinical Applications. Wiley & Sons, Incorporated, John, 2009.
Trouver le texte intégral(Editor), Dirk Nagorsen, et F. M. Marincola (Editor), dir. Analyzing T Cell Responses : How to analyze cellular immune responses against tumor associated antigens. Springer, 2005.
Trouver le texte intégralMarincola, Francesco M., et Dirk Nagorsen. Analyzing T Cell Responses : How to Analyze Cellular Immune Responses Against Tumor Associated Antigens. Springer London, Limited, 2006.
Trouver le texte intégralMarincola, Francesco M., et Dirk Nagorsen. Analyzing T Cell Responses : How to Analyze Cellular Immune Responses Against Tumor Associated Antigens. Springer, 2010.
Trouver le texte intégralChapitres de livres sur le sujet "Antigeni tumore associati"
Chabannon, Christian, et Chiara Bonini. « Structure of and Signalling Through Chimeric Antigen Receptor ». Dans The EBMT/EHA CAR-T Cell Handbook, 3–5. Cham : Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94353-0_1.
Texte intégralWard, Tony Milford. « Cancer Associated Antigens ». Dans Proteins and Tumour Markers May 1995, 932–33. Dordrecht : Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0681-8_11.
Texte intégralAnderson, Byron, Lyman E. Davis et Mario Venegas. « Tumor-Associated Blood Group Antigen Expressions and Immunoglobulins Associated with Tumors ». Dans The Molecular Immunology of Complex Carbohydrates, 601–56. Boston, MA : Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1663-3_25.
Texte intégralPaganuzzi, M., M. Onetto, P. Marroni, G. Valenti, F. Boccardo et L. Santi. « CLINICAL EVALUATION OF NEW TUMOR-ASSOCIATED ANTIGENS ». Dans Human Tumor Markers, sous la direction de F. Cimino, G. D. Birkmayer, J. V. Klavins, E. Pimentel et F. Salvatore, 643–56. Berlin, Boston : De Gruyter, 1987. http://dx.doi.org/10.1515/9783110846515-047.
Texte intégralMian, Shahid, R. Adrian Robins, Robert C. Rees et Bernie Fox. « Immunogenicity of tumour associated antigens ». Dans Cancer Immunology, 1–26. Dordrecht : Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-017-0963-7_1.
Texte intégralKlein, George. « Virus-Induced, Tumour-Associated Antigens ». Dans Ciba Foundation Symposium - Strategy of the Viral Genome, 295–315. Chichester, UK : John Wiley & Sons, Ltd., 2008. http://dx.doi.org/10.1002/9780470719824.ch17.
Texte intégralZhi-Wei, Dong, Wei Shu-Min, Li Zhen-Pu, Wan Wen-Hui et Xu Xin-Lai. « A Study of Tumor-Associated Antigens ». Dans Cancer of the Liver, Esophagus, and Nasopharynx, 135–43. Berlin, Heidelberg : Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71510-5_21.
Texte intégralÁlvarez-Fernández, Sheila María, Lucia De Monte et Massimo Alessio. « Natural Antibodies to Tumor-Associated Antigens ». Dans Methods in Molecular Biology, 11–25. New York, NY : Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3338-9_2.
Texte intégralRuiter, D. J., E.-B. Broecker, C. Vennegoor et S. Ferrone. « Monoclonal Antibodies Recognizing Melanoma-Associated Antigens. » Dans Application of Monoclonal Antibodies in Tumor Pathology, 131–65. Dordrecht : Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3299-9_8.
Texte intégralHounsell, E. F., H. C. Gooi et T. Feizi. « Tumour-Associated Carbohydrate Antigens of Glycoproteins ». Dans Investigation and Exploitation of Antibody Combining Sites, 317–22. Boston, MA : Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-5006-4_38.
Texte intégralActes de conférences sur le sujet "Antigeni tumore associati"
Rickles, F. R., W. W. Hancock, K. Kobzik, N. Hogg et C. O’Hara. « THE DISTRIBUTION OF CROSS-LINKED FIBRIN IN HUMAN LUNG CARCINOMA PARALLELS THAT OF ACTIVATED HOST MONONUCLEAR LEUKOCYTES : IMMUNO-HISTOLOGIC STUDIES WITH MONOCLONAL ANTIBODIES ». Dans XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643669.
Texte intégralThomas, Dhanya S., Ajit Sebastian, Vinotha Thomas, Anitha Thomas, Rachel Chandy et Abraham Peedicayil. « Role of cancer antigen 19-9 in complex ovarian tumors ». Dans 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685315.
Texte intégralThomas, Dhanya S., Ajit Sebastian, Vinotha Thomas, Anitha Thomas, Rachel Chandy et Abraham Peedicayil. « Role of CA 19-9 in complex ovarian tumors ». Dans 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685299.
Texte intégralBanerjee, Rupak K., Meinrad Praxmaraer, Ilhan Dilber, Peter Bungay, William van Osdol et Cynthia Sung. « Numerical Simulation of Antibody Penetration in a Solid Tumor Nodule Using Finite Element Method ». Dans ASME 1998 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1998. http://dx.doi.org/10.1115/imece1998-0058.
Texte intégralPandey, Divya, Neha Pruthi et Sudha Salhan. « Unusually high serum Ca 19-9 in a benign ovarian tumor ». Dans 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685327.
Texte intégralBuonaguro, L. « P03.06 Tumor associated antigens and pathogen antigens : friends or foes ». Dans iTOC9 – 9th Immunotherapy of Cancer Conference, September 22–24, 2022 – Munich, Germany. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-itoc9.34.
Texte intégralAthanassiou, P., A. Elezoglou, I. Kostoglou-Athanassiou, A. Theodorou, P. Konstantopoulou, A. Kotrotsios, P. Dimou et G. Vezyroglou. « THU0197 Tumour-associated antigens in rheumatoid arthritis ». Dans Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.1099.
Texte intégralBarroilhet, Lisa M., Junzheng Yang, William R. Welch, Ross S. Berkowitz et Shu-Wing Ng. « Abstract 2734 : Tumor-associated antigen c-terminal binding protein-2 is overexpressed in epithelial ovarian tumors ». Dans Proceedings : AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010 ; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2734.
Texte intégralToner, K., M. Stanojevic, M. Grant, R. Schore, A. Gross, D. Couriel, B. Hu et al. « Tumor associated antigen specific T cells for Hodgkin Lymphoma ». Dans ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701880.
Texte intégralLima, Beatriz Alves, Andressa da Silva Pereira, Bruna Alves Lima, Diana Gonçalves Lima, Leonardo Ferreira Pucci, Renato Moraes Ferreira, Tiago Castro Ferreira et Henrique Ferreira Pucci. « PREDICTORS OF BREAST CANCER PROGNOSIS BASED ON TUMOR BIOMARKERS ». Dans Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2022.
Texte intégralRapports d'organisations sur le sujet "Antigeni tumore associati"
Tiwari, Raj K. Tumor Associated Antigenic Peptides in Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, mars 2002. http://dx.doi.org/10.21236/ada406458.
Texte intégralTiwari, Raj. Tumor Associated Antigenic Peptides in Prostate Cancer. Fort Belvoir, VA : Defense Technical Information Center, octobre 1999. http://dx.doi.org/10.21236/ada383084.
Texte intégralHampton, Tracy A. Identification and Characterization of Tumor Antigens Associated With Breast Cancer. Fort Belvoir, VA : Defense Technical Information Center, août 1998. http://dx.doi.org/10.21236/adb244675.
Texte intégralBai, Jining. Identification of Widely Applicable Tumor-Associated Antigens for Breast Cancer Immunotherapy. Fort Belvoir, VA : Defense Technical Information Center, octobre 2004. http://dx.doi.org/10.21236/ada432926.
Texte intégralBai, Jining. Identification of Widely Applicable Tumor-Associated Antigens for Breast Cancer Immunotherapy. Fort Belvoir, VA : Defense Technical Information Center, octobre 2002. http://dx.doi.org/10.21236/ada411919.
Texte intégralBai, Jining. Identification of Widely Applicable Tumor-Associated Antigens for Breast Cancer Immunotherapy. Fort Belvoir, VA : Defense Technical Information Center, janvier 2006. http://dx.doi.org/10.21236/ada588103.
Texte intégralKim, Hyunjin M., et Samuel Danishefshky. A Solid Support Synthesis and Novel Conjugation Methods of Breast Tumor Associated Antigen : Toward the Development of Cancer Vaccines. Fort Belvoir, VA : Defense Technical Information Center, juillet 1999. http://dx.doi.org/10.21236/ada373924.
Texte intégralLong, Brian R., et Roland M. Tisch. The Use of Venezuelan Equine Encephalitis Encoding the Her-2/neu Tumor Associated Antigen for the Prevention and Treatment of Breast Cancer. Fort Belvoir, VA : Defense Technical Information Center, mai 2003. http://dx.doi.org/10.21236/ada416667.
Texte intégralLong, Brian R., et Roland M. Tisch. The Use of Venezuelan Equine Encephalitis Replicons Encoding the HER-2/neu Tumor Associated Antigen for the Prevention and Treatment of Breast Cancer. Fort Belvoir, VA : Defense Technical Information Center, mai 2004. http://dx.doi.org/10.21236/ada428256.
Texte intégralEvans, Donald L., Avigdor Eldar, Liliana Jaso-Friedmann et Herve Bercovier. Streptococcus Iniae Infection in Trout and Tilapia : Host-Pathogen Interactions, the Immune Response Towards the Pathogen and Vaccine Formulation. United States Department of Agriculture, février 2005. http://dx.doi.org/10.32747/2005.7586538.bard.
Texte intégral